Psychopharmacology Update

Price: $155.00

Significant new developments as well as controversies have taken place in psychopharmacology during the past two years.

This workshop addresses: potential problems with suicidality in children and teenagers treated with antidepressants, childhood onset bipolar disorder (differential diagnosis and treatment), new diagnostic criteria for bipolar spectrum disorders, new bipolar medications, empirically derived treatment guidelines for ADHD and for major depression, new studies on over-the-counter products such as St. John’s Wort, Omega-3 fatty acids, and SAM-e, and finally, the role of psychotropic drugs in protecting and healing the brain (neuro-protection).

The Web Lectures for this class provide 6 hours of CE credit.

Learning Objectives:

Describe three warning signs of a bi-polar disorder

Name at least three anti-depressants, and characterize possible adverse side effects.
To appreciate the limitations of pharmacologic treatments and the need for integrated approaches.

Identify at least three over-the-counter products and their possible psychotherapeutic uses and limitations.

. . . . . . . .

John Preston, PsyD, is a faculty member at Alliant International University and has also taught at the University of California, Davis, School of Medicine, Department of Family and Community Medicine. Dr. Preston is the author of eleven books on various topics including Handbook of Clinical Psychopharmacology for Therapists. He is also the author of Drugs in Psychiatry, a chapter in the Encyclopedia Americana. Dr. Preston is the recipient of the Mental Health Association’s President’s Award for contributions to the mental health community. He has lectured widely in the United States, Europe and Russia.